The collaboration aims to leverage innovative biomanufacturing technology to accelerate personalized therapies for cardiovascular patients worldwide.
The funds will help expand and secure Canada's cell based therapy supply chain.
The new Princeton facility will boost BioCentriq's capacity, helping clients accelerate innovative cell therapies from development to commercialization.
Terumo Blood and Cell Technologies (Terumo BCT) and Akron Bio say they've completed a collaborative study demonstrating equivalency between research-use-only (RUO) and Good Manufacturing Practices (GMP)-grade fibronectin for expanding mesenchymal stem cells...
AMSBIO has introduced its GMP-grade StemFit® for Differentiation, a medium designed for the differentiation of human induced pluripotent stem (hiPS) and embryonic stem (hES) cells. This formulation, now compliant with Good Manufacturing...
Pandorum and AGC have teamed up to produce Pandorum's flagship exosome product Kuragenx, which they refer to as a 'liquid cornea'. Pandorum says that Kuragenx has demonstrated promising results in the preclinical...
